Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

24. Dezember 2025 08:36 ET | Quelle: Teva Pharmaceutical Industries Ltd

S&P Global Ratings Upgrades Teva to ‘BB+’ Amid Strong Execution of Pivot to Growth Strategy; Moody's Ratings Agency Revises Outlook to Positive

The two updates underscore Teva’s strong execution of its Pivot to Growth strategy and commitment to financial discipline.Moody's affirmed Teva's B1a rating and revised Teva's outlook to positive from...
23. Dezember 2025 16:46 ET | Quelle: Can-Fite BioPharma Ltd.

Can-Fite Announces Reverse Split of its Ordinary Shares and ADS Ratio Change

RAMAT GAN, Israel, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Can-Fite BioPharma Ltd. (NYSE American: CANF) (TASE: CANF), a biotechnology company advancing a pipeline of proprietary small-molecule drugs...
23. Dezember 2025 08:05 ET | Quelle: Foresight Autonomous Holdings Ltd.

Foresight Expands Road Safety Product Outreach in South Korea with a Strategic Cooperation Agreement

Ness Ziona, Israel, Dec. 23, 2025 (GLOBE NEWSWIRE) -- Foresight Autonomous Holdings Ltd. (Nasdaq and TASE: FRSX) (“Foresight” or the “Company”), an innovator in 3D perception systems, announced...
22. Dezember 2025 16:30 ET | Quelle: ZOOZ Strategy Ltd.

ZOOZ Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

TEL AVIV, Israel, Dec. 22, 2025 (GLOBE NEWSWIRE) -- ZOOZ Strategy Ltd. (Nasdaq and TASE: ZOOZ) (“ZOOZ” or the “Company”) announced today that the Company received a notification letter (the...
22. Dezember 2025 07:30 ET | Quelle: BrainsWay

BrainsWay Reports Expansion of Adolescent Depression Coverage Applicable to Deep TMS™

BURLINGTON, Mass. and JERUSALEM, Dec. 22, 2025 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive brain stimulation...
22. Dezember 2025 07:00 ET | Quelle: Pluri Inc.

Pluri and Remedy Cell Expand Collaboration; Successful Engineering Runs and Clinical-Grade Manufacturing Achieved

HAIFA, Israel, Dec. 22, 2025 (GLOBE NEWSWIRE) -- Pluri, Inc. (“Pluri”, the “Company”, “we” or “us”) (Nasdaq, TASE: PLUR), a leading biotechnology company leveraging its proprietary platform for...
19. Dezember 2025 03:40 ET | Quelle: Teva Pharmaceutical Industries Ltd

Alvotech and Teva Secure U.S. Settlement Date for AVT06, a Proposed Biosimilar to Eylea®

According to the settlement agreement, the proposed biosimilar to Eylea® (aflibercept) can be marketed in the U.S., if approved by the FDA, in the fourth quarter of 2026, or earlier under certain...
18. Dezember 2025 07:00 ET | Quelle: Kamada Ltd.

Kamada Announces a $10-$14 Million Extension of Canadian Supply Tender

Company Awarded Extension to Existing Supply Tender Relating to its Portfolio of Four Specialty Plasma-Derived ProductsSupply Extension Secures Ongoing Sales of Approximately $5.0-$7.0 Million Per...
17. Dezember 2025 07:30 ET | Quelle: Nayax Ltd.

Nayax Partners with Unipaas to Launch Fully Integrated Card-Present Payments Solution for UK SaaS Platforms

Nayax partner with Unipass to deliver a fully unified card present and online payments solution for SaaS platforms in the UK
16. Dezember 2025 16:30 ET | Quelle: Ellomay Capital Ltd

Ellomay Capital Announces Execution of an Agreement to Sell the Control Stake in the Company to O.Y. Nofar Energy Ltd.

Mr. Ran Fridrich will continue as Chief Executive Officer of the Company Tel-Aviv, Israel, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Ellomay Capital Ltd. (NYSE American; TASE: ELLO) (“Ellomay” or the...

Nächste Seite